Add like
Add dislike
Add to saved papers

Antimicrobial activity of Bacillus subtilis s ilver nanoparticles.

We tested the hypothesis that silver nanoparticles (BsAgNPs) made by Bacillus subtilis subsp. inaquosorum exhibit antibacterial and antifungal activities. The bacteria formed nanoparticles in UV-visible spectra with the peak around 430 nanometer detected by surface plasmon resonance and Lambdamax. The FTIR spectra, SEM and XRD revealed the involvement of interaction of biological moieties in the formation of crystalline cuboidal nanoparticles that were had an average size of 10-20 nm. The particles exerted dose dependent antibacterial and antifungal activities and high dose equivalent to standard antibiotics. Minimum inhibitory concentration, minimum bactericidal and fungicidal concentrations were in the range from 3.1-25 microgram/ml and 6.3-50 microgram/ml, respectively. BsAgNPs significantly inhibited the growth of multiple strains including multidrug resistant (MDR) bacteria. Moreover, the combination of BsAgNPs and antibiotics showed synergistic inhibition of MDR strains. These data show that BsAgNPs have a great potential in the treatment of MDR bacteria without or with standard antibiotics.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app